These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27650354)

  • 21. DNA synergistic enzyme-mediated cascade reaction for homogeneous electrochemical bioassay.
    Zhang Y; Cao X; Deng R; Liu Q; Xia J; Wang Z
    Biosens Bioelectron; 2019 Oct; 142():111510. PubMed ID: 31319327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorogenic quantum dot-gold nanoparticle assembly for beta secretase inhibitor screening in live cell.
    Choi Y; Cho Y; Kim M; Grailhe R; Song R
    Anal Chem; 2012 Oct; 84(20):8595-601. PubMed ID: 22954333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The selective BACE1 inhibitor VIa reduces amyloid-β production in cell and mouse models of Alzheimer's disease.
    Cheng X; Zhou Y; Gu W; Wu J; Nie A; Cheng J; Zhou J; Zhou W; Zhang Y
    J Alzheimers Dis; 2013; 37(4):823-34. PubMed ID: 23948917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
    Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
    J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tetrapeptides, as small-sized peptidic inhibitors; synthesis and their inhibitory activity against BACE1.
    Kakizawa T; Hidaka K; Hamada D; Yamaguchi R; Uemura T; Kitamura H; Tagad HD; Hamada T; Ziora Z; Hamada Y; Kimura T; Kiso Y
    J Pept Sci; 2010 Jun; 16(6):257-62. PubMed ID: 20474036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer's mice.
    Li S; Hou H; Mori T; Sawmiller D; Smith A; Tian J; Wang Y; Giunta B; Sanberg PR; Zhang S; Tan J
    Sci Rep; 2015 Jun; 5():11322. PubMed ID: 26091071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishing the relationship between in vitro potency, pharmacokinetic, and pharmacodynamic parameters in a series of orally available, hydroxyethylamine-derived β-secretase inhibitors.
    Wood S; Wen PH; Zhang J; Zhu L; Luo Y; Babu-Khan S; Chen K; Pham R; Esmay J; Dineen TA; Kaller MR; Weiss MM; Hitchcock SA; Citron M; Zhong W; Hickman D; Williamson T
    J Pharmacol Exp Ther; 2012 Nov; 343(2):460-7. PubMed ID: 22911925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spirocyclic β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: from hit to lowering of cerebrospinal fluid (CSF) amyloid β in a higher species.
    Hunt KW; Cook AW; Watts RJ; Clark CT; Vigers G; Smith D; Metcalf AT; Gunawardana IW; Burkard M; Cox AA; Geck Do MK; Dutcher D; Thomas AA; Rana S; Kallan NC; DeLisle RK; Rizzi JP; Regal K; Sammond D; Groneberg R; Siu M; Purkey H; Lyssikatos JP; Marlow A; Liu X; Tang TP
    J Med Chem; 2013 Apr; 56(8):3379-403. PubMed ID: 23537249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring human beta-secretase (BACE1) activity using homogeneous time-resolved fluorescence.
    Kennedy ME; Wang W; Song L; Lee J; Zhang L; Wong G; Wang L; Parker E
    Anal Biochem; 2003 Aug; 319(1):49-55. PubMed ID: 12842106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
    Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of amyloid beta-peptide production by blockage of beta-secretase cleavage site of amyloid precursor protein.
    Na CH; Jeon SH; Zhang G; Olson GL; Chae CB
    J Neurochem; 2007 Jun; 101(6):1583-95. PubMed ID: 17542811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iminoheterocycle as a druggable motif: BACE1 inhibitors and beyond.
    Zhu Z
    Trends Pharmacol Sci; 2012 May; 33(5):233-40. PubMed ID: 22480948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A sensitive and selective electrochemical biosensor for the determination of beta-amyloid oligomer by inhibiting the peptide-triggered in situ assembly of silver nanoparticles.
    Xing Y; Feng XZ; Zhang L; Hou J; Han GC; Chen Z
    Int J Nanomedicine; 2017; 12():3171-3179. PubMed ID: 28458538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fragment-based designing for the generation of novel leads against BACE1.
    Das S; Chakraborty S; Basu S
    Cent Nerv Syst Agents Med Chem; 2015; 15(1):52-64. PubMed ID: 25625854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrochemical detection of β-amyloid peptides on electrode covered with N-terminus-specific antibody based on electrocatalytic O2 reduction by Aβ(1-16)-heme-modified gold nanoparticles.
    Liu L; Zhao F; Ma F; Zhang L; Yang S; Xia N
    Biosens Bioelectron; 2013 Nov; 49():231-5. PubMed ID: 23770394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of peptides derived from BACE1 catalytic domain on APP processing.
    Yeon SW; Jeon YJ; Hwang EM; Kim TY
    Peptides; 2007 Apr; 28(4):838-44. PubMed ID: 17293005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A peptide-WS
    Zuo X; Dai H; Zhang H; Liu J; Ma S; Chen X
    Analyst; 2018 Sep; 143(19):4585-4591. PubMed ID: 30156585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ginsenoside Re reduces Aβ production by activating PPARγ to inhibit BACE1 in N2a/APP695 cells.
    Cao G; Su P; Zhang S; Guo L; Zhang H; Liang Y; Qin C; Zhang W
    Eur J Pharmacol; 2016 Dec; 793():101-108. PubMed ID: 27840193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simple and sensitive electrochemical sensor for the detection of peptidase activity.
    Dai T; Qiu M; Li H; Yang M; Gao J; Li X; Lv J; Yang M; Yuan Z; Luo J
    Anal Bioanal Chem; 2023 May; 415(12):2209-2215. PubMed ID: 36856821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformational transition in the substrate binding domain of β-secretase exploited by NMA and its implication in inhibitor recognition: BACE1-myricetin a case study.
    Chakraborty S; Kumar S; Basu S
    Neurochem Int; 2011 Jul; 58(8):914-23. PubMed ID: 21354237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.